Summary:
- This article provides a comprehensive narrative review of the XEN63 gel stent, a micro-invasive glaucoma surgery (MIGS) device designed to reduce intraocular pressure by facilitating aqueous humor drainage.
- The authors analyze clinical efficacy, safety profiles, and surgical techniques, offering expert perspectives on how this iteration compares to previous stent generations in the management of refractory glaucoma.